Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01406860 · ClinicalTrials.gov registry record · NA
Droperidol Versus Metoclopramide + Diphenhydramine for the Treatment of Primary Headaches
A NA study, sponsored by University of Iowa.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01406860: Clinical Trial NA study, sponsored by University of Iowa.
NCT01406860 is a NA study that was terminated before completion, run by University of Iowa. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01406860, a NA study, was terminated before completion, sponsored by University of Iowa.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if droperidol is equally as effective as metoclopramide for treatment of primary headaches in the Emergency Department.
Primary Outcome
Numerical Rating Scale for Pain on a scale of 0-10 with 10 representing the worst pain
Interventions
- DRUG Droperidol
- DRUG Metoclopramide + diphenhydramine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-07 |
| Phase | NA |
Why NCT01406860 stopped before completion
NCT01406860 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Droperidol is the first listed.
NCT01406860 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01406860 about?
NCT01406860 is a clinical study titled "Droperidol Versus Metoclopramide + Diphenhydramine for the Treatment of Primary Headaches". The purpose of this study is to determine if droperidol is equally as effective as metoclopramide for treatment of primary headaches in the Emergency Department.
What is the current status of trial NCT01406860?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2011-07. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01406860?
The interventions under investigation include: Droperidol (DRUG), Metoclopramide + diphenhydramine (DRUG).
Who is sponsoring clinical trial NCT01406860?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01406860's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia